A Collaborative Study of Proposed European Pharmacopoeia Reference Preparations of Low Molecular Mass Heparin

Summary

A European collaborative study, in which 16 laboratories participated, was carried out to assess the performance of the European Pharmacopoeia (EP) monograph methods for anticoagulant activities (anti-Xa and anti-IIa assays) of low molecular mass (EMM) heparin and to assess the suitability of six candidate materials as the EP working standard for LMM heparin. There was good interlaboratory agreement for both types of assays as indicated by most gcv’s being less than 10%, indicating acceptable performance of the EP assay methods. All the candidate preparations gave dose-response curves parallel to the 1st International Standard for Low Molecular Weight heparin and to each other. All preparations, possibly with the exception of E and F, gave similar performance as measured by interlaboratory agreement and would be suitable as working standards. Based on these data, preparations A, B, C and D have been established by the EP as official EP Biological Reference Preparations and they will be issued as successive batches.

• References

• 1 Hull RD, Pineo GF. Therapeutic use of low molecular weight heparins: knowledge to date and their application to therapy. Seminars in Thromb Haemost 1994; 20: 339-344
• 2 Rosendaal FR, Nurmohamed MT, Büller HR, Dekker E, Vandenbroucke JP, Briüt E. Low molecular weight heparin in the prophylaxis of venous thrombosis: A meta-analysis. Thromb Haemost 1991; 65: 927
• 3 Nurmohamed MT, Rosendaal FR, Büller HR, Dekker E, Hommes DW, Vandenbroucke JP, Briët E. Low molecular weight heparin versus standard heparin in general and orthopaedic surgery: a meta-analysis. The Lancet 1992; 340: 152-156
• 4 Barrowcliffe TW, Curtis AD, Tomlinson TP, Hubbard AR, Johnson EA, Thomas DP. Standardization of low molecular weight heparins: a collaborative study. Thromb Haemost 1985; 54: 675-679
• 5 Barrowcliffe TW, Curtis AD, Johnson EA, Thomas DP. An International standard for low molecular weight heparin. Thromb Haemost 1988; 60: 1-7
• 6 Low molecular mass heparins (assay for anticoagulant activities). Pharmeuropa. 1991; 3: 161-165
• 7 van Dedem G, Nielsen JI. Determination of the molecular mass of low molecular mass (LMM) heparin. Pharmeuropa 1991; 3: 202-218
• 8 Kirkwood TB L. Predicting the stability of biological standards and products. Biometrics 1977; 33: 736-742